The landscape of diabetes care is advancing with the arrival of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to injections for individuals living with diabetes 2. They deliver glucagon-like peptide-1 directly through the epidermis, avoiding the need for regular injections and potentially improving compl… Read More